In recent years, various mechanisms of the actions of berberine on AD have been gradually discovered and reported, including the inhibition of Aβ deposition, the inhibition of cholinesterase and monoamine oxidase, and the delay of the occurrence of neuroinflammation and oxidative stress (Gao and Chu, 2017). This evidence concerns the gene BCHE and Alzheimer disease.